Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

54.94
Delayed Data
As of 4:02pm ET
 +0.30 / +0.55%
Today’s Change
37.90
Today|||52-Week Range
56.69
+43.04%
Year-to-Date

Today’s Trading

Previous close54.64
Today’s open54.77
Day’s range54.48 - 55.12
Volume4,273,000
Average volume (3 months)5,366,044
Market cap$95.1B
Dividend yield1.93%
Data as of 4:02pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.52%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+2.20%
P/E ratio45.8
Price/Sales2.73
Price/Book3.92

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.22+0.25%
NVONovo Nordisk+0.29+0.56%
GSKGlaxoSmithKline+0.14+0.40%
BMYBristol-Myers Squibb+0.60+0.96%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$0.73
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts